Casi PharmaceuticalsCASIF
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 20 institutions reported holding Casi Pharmaceuticals Inc. (CASIF) in their 13F filings, down 3 from Q2 2024. 2 opened new positions and 5 sold out. The largest holders were Venrock Adviser, LLC ($6.1M), Wellington Shields Capital Management, LLC ($550K) and ADAR1 Capital Management, LLC ($399K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Casi Pharmaceuticals Inc.
- CUSIP
- G1933S101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $323K |
| Exits | 5 | $89K |
All 13F filers, Q2 2024 → Q3 2024: 989,474 shares bought and 19,115 shares sold, net +970,359 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Venrock Adviser, LLC | 0.32% | Add +784.0% | 987,259 | $6.1M |
| Wellington Shields Capital Management, LLC | 0.10% | No change | 89,217 | $550K |
| ADAR1 Capital Management, LLC | 0.07% | Add +686.8% | 64,835 | $399K |
| Wellington Shields & Co., LLC | 0.08% | No change | 43,091 | $265K |
| Renaissance Technologies | 0.00% | Add +1.7% | 41,500 | $256K |
| Woodline Partners LP | 0.00% | New | 30,532 | $188K |
| Citadel Advisors | 0.00% | New | 22,714 | $135K |
| Geode Capital Management, LLC | 0.00% | Reduce -12.9% | 19,363 | $115K |
| UBS Group AG | 0.00% | Add +29.7% | 14,681 | $90K |
| Royal Bank of Canada | 0.00% | No change | 6,900 | $43K |
| Morgan Stanley | 0.00% | No change | 1,440 | $9K |
| Wells Fargo & Company | 0.00% | No change | 506 | $3K |
| BlackRock, Inc. | 0.00% | — | 296 | $2K |
| West Paces Advisors Inc. | 0.00% | No change | 100 | $616 |
| Bank of America Corp. | 0.00% | Reduce -47.2% | 28 | $172 |
| JPMorgan Chase & Co. | 0.00% | No change | 25 | $149 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 13 | $80 |
| Colonial Trust Co / SC | 0.00% | No change | 11 | $68 |
| Trust Co. of Vermont | 0.00% | No change | 10 | $62 |
| Osaic Holdings, Inc. | 0.00% | No change | 8 | $49 |
"% of holder's portfolio" is CASIF's weight in each manager's 13F, not the share of Casi Pharmaceuticals Inc. the manager owns.